Changes in patterns of practice for prostate cancer radiotherapy in Italy 1995-2003. A survey of the Prostate Cancer Study Group of the Italian Radiation Oncology Society

Tumori

Volumn 100, Issue 1, 2014, Pages 31-37

  Pegurri, Ludovica ^a   Buglione, Michela ^a   Girelli, Giovanni ^b   Guarnieri, Alessia ^c   Meattini, Icro ^d   Ricardi, Umberto ^c   Mangoni, Monica ^d   Gabriele, Pietro ^e   Bellavita, Rita ^f   Krengli, Marco ^g   Bonetta, Alberto ^h   Cagna, Emanuela ⁱ   Bunkheila, Feisal ^j   Borghesi, Simona ^k   Signor, Marco ^l   Di Marco, Adriano ^m   Bertoni, Filippo ⁿ   Stefanacci, Marco ^o   Gatta, Roberto ^a   De Bari, Berardino ^a,p   Magrini, Stefano Maria ^a   more..

^a UNIVERSITY OF BRESCIA   (Italy)

^b Ospedale di Ivrea   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF FLORENCE   (Italy)

^e Radiation Oncology Dept Fondazione Piemontese per la Ricerca sul Cancro   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^h CREMONA HOSPITAL   (Italy)

ⁱ Sant'Anna Como Hospital   (Italy)

^j UNIVERSITY OF BOLOGNA   (Italy)

^k Arezzo Hospital   (Italy)

^l UNIVERSITY HOSPITAL OF UDINE   (Italy)

^m Ospedale Mantova   (Italy)

ⁿ Modena Hospital   (Italy)

^o PISTOIA HOSPITAL   (Italy)

^p LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

Patterns of practice; Pro state cancer; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER RADIOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLINICAL PRACTICE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; DISEASE SPECIFIC SURVIVAL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATIENT SAFETY; PROSTATE CANCER; RADIATION DOSE; RADIATION INJURY; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEALTH CARE SURVEYS; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SOCIETIES, MEDICAL; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84894229015     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/1430.15812     Document Type: Article

References (21)

1. 1 NCCN: Guidelines for treatment of cancer by site: Prostate. Available at http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf
2. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N, Schmid HP, van der Kwast T, Wiegel T, Zattoni F: European Association of Urology EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol, 59: 61-71, 2011.
3. Mottet N, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Schmid HP, Van der Kwast T, Wiegel T, Zattoni F, Heidenreich A: EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol, 59: 572-583, 2011.
4. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM, Hunt M, Wolfe T, Venkatraman ES, Jackson A, Skwarchuk M, Leibel SA: Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol, 55: 241-249, 2000.
5. Staffurth J, Radiotherapy Development Board: A review 5. of the clinical evidence for intensity-modulated radiotherapy. Clin Oncol (R Coll Radiol), 22: 643-657, 2010.
6. Fogarty GB, Ng D, Liu G, Haydu LE, Bhandari N: Volumetric modulated arc therapy is superior to conventional intensity modulated radiotherapy - a comparison among prostate cancer patients treated in an Australian centre. Radiat Oncol, 6: 108, 2011.
7. Rong Y, Tang G, Welsh JS, Mohiuddin MM, Paliwal B, Yu CX: Helical tomotherapy versus single-arc intensity-modulated arc therapy: a collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys, 81: 284-296, 2011.
8. Davidson MT, Blake SJ, Batchelar DL, Cheung P, Mah K: Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer. Int J Radiat Oncol Biol Phys, 80: 1550-1558, 2011.
9. Davidson MT, Blake SJ, Batchelar DL, Cheung P, Mah K: Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: a systematic review. Radiother Oncol, 93: 168-173, 2009.
10. Sullivan R, Peppercorn J, Sikora K, Zalcberg J, Meropol NJ, Amir E, Khayat D, Boyle P, Autier P, Tannock IF, Fojo T, Siderov J, Williamson S, Camporesi S, McVie JG, Purushotham AD, Naredi P, Eggermont A, Brennan MF, Steinberg ML, De Ridder M, McCloskey SA, Verellen D, Roberts T, Storme G, Hicks RJ, Ell PJ, Hirsch BR, Carbone DP, Schulman KA, Catchpole P, Taylor D, Geissler J, Brinker NG, Meltzer D, Kerr D, Aapro M: Delivering affordable cancer care in high-income countries. Lancet Oncol, 12: 933-980, 2011.
11. Bekelman JE, Shah A, Hanh S: Implications of comparative effectiveness research for radiation oncology. Pract Radiat Oncol, 1: 72-80, 2011.
12. Magrini SM, Bertoni F, Vavassori V, Villa S, Cagna E, Maranzano E, Pertici M, Pradella R, Spediacci MA, Chiavacci A, Ambrosi E, Livi L, Magli A, Bellavita R, Bossi A, Biti G: Practice patterns for prostate cancer in nine central and northern Italy radiation oncology centers: a survey including 1759 patients treated during two decades (1980-1998). Int J Radiat Oncol Biol Phys, 52: 1310-1319, 2002.
13. American Society for Therapeutic Radiology and Oncology Consensus Panel: Consensus statement: Guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys, 17: 1155, 1994.
14. RTOG/EORTC late radiation morbidity scoring schema. Available at http://www.rtog.org/ResearchAssociates/AdverseEventReporting/ RTOGEORTCLateRadiationMorbidityScoringSchema.aspx
15. Pickles T, Kim-Sing C, Morris WJ, Tyldesley S, Paltiel C: Evaluation of the Houston biochemical relapse definition in men treated with prolonged neoadjuvant and adjuvant androgen ablation and assessment of follow-up lead-time bias. Int J Radiat Oncol Biol Phys, 57: 11-18, 2003.
16. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A: Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA, 280: 969-974, 1998.
17. Chapet O, Quero L, Azria D, Bossi A, Hennequin C, Paparel P: Is pelvic irradiation still justified in the treatment of prostate cancer by exclusive radiotherapy? Cancer Radiother, 13: 416-422, 2009.
18. Kuban DA, Tucker SL, Dong L, Starkschall G, Huang EH, Cheung MR, Lee AK, Pollack A: Long-term results of the M. D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys, 70: 67-74, 2008.
19. Al-Mamgani A, van Putten WL, Heemsbergen WD, van Leenders GJ, Slot A, Dielwart MF, Incrocci L, Lebesque JV: Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys, 72: 980-988, 2008.
20. Beckendorf V, Guerif S, Le Prisé E, Cosset JM, Bougnoux A, Chauvet B, Salem N, Chapet O, Bourdain S, Bachaud JM, Maingon P, Hannoun-Levi JM, Malissard L, Simon JM, Pommier P, Hay M, Dubray B, Lagrange JL, Luporsi E, Bey P: 70 Gy versus 80 Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys, 80: 1056-1063, 2011.
21. De Bari B, Fiorentino A, Greto D, Ciammella P, Arcangeli S, Avuzzi B, D'Angelillo RM, Desideri I, Kirienko M, Marchiori D, Massari F, Fundoni C, Franco P, R. Filippi AR, Alongi F: Prostate cancer as a paradigm of multidisciplinary approach? Highlights from the young radiation oncologist meeting. Tumori, 99: 637-649, 2013.